Solutions
AI-First Discovery Platform
Natural Compound Library
Bioactivity Prediction Models
Therapeutics
NB-A002 (DDR/HRD Cancers)
Nutraceuticals
Botanical Research Portfolio
Research Areas & Innovation Platform
Company
About Us
Newsroom
Publications
Careers
Partners
Collaborations
Strategic Tech Alliances
Accelerators
Discovery & Industry Partners
Research & Academic Partners
Commercial & Distribution Partners
Contact Us
Newsroom
Company
June 1, 2026
Featured at NVIDIA GTC Taiwan 2026: NYB.AI Stands Alongside the World’s Leading AI Innovators
NYB.AI, the AI drug discovery spinoff of NYB Group, was featured in a video during Jensen Huang's keynote at NVIDIA GTC Taiwan 2026 — recognised among the world's leading AI innovators from NVIDIA Inception's ecosystem of 25,000+ startups.
Read more
View All
Partnership
Case Studies
Publications
Company
Company
June 1, 2026
Featured at NVIDIA GTC Taiwan 2026: NYB.AI Stands Alongside the World’s Leading AI Innovators
NYB.AI, the AI drug discovery spinoff of NYB Group, was featured in a video during Jensen Huang's keynote at NVIDIA GTC Taiwan 2026 — recognised among the world's leading AI innovators from NVIDIA Inception's ecosystem of 25,000+ startups.
Read more
Company
March 23, 2026
NYB Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum
NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Read more
Company
February 25, 2026
NYB to Exhibit at NVIDIA GTC 2026
NYB is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.
Read more
Case Studies
February 23, 2026
How AI Discovered 3,500 Mental Wellness Compounds in 5 Months — What Took Traditional Labs Years
NYB's Vecura platform, powered by NVIDIA GPU infrastructure, is rewriting the rules of natural ingredient discovery.
Read more
Peer-Reviewed Publications
December 12, 2025
Introducing LigoSPACE: Advancing Bioactivity Prediction at NeurIPS 2025
NYB and NTU Singapore presented LigoSPACE at NeurIPS 2025, one of the world’s most prestigious conferences in AI and ML.
Read more
Press
November 19, 2025
[The Business Times] Singapore biotech startup NYB bets on AI drug discovery platform to unlock revenue
NYB is featured in The Business Times following its planned Nasdaq listing through a US$1.5 billion SPAC deal and the signing of its first client.
Read more
Partnership
October 2, 2025
NYB Announces $1.5 Billion Business Combination with RF Acquisition Corp II to Pursue Nasdaq Listing
NYB announced a business combination agreement with RF Acquisition Corp II to pursue a Nasdaq listing.
Read more
Partnership
September 3, 2025
Powering Life Sciences and Health Innovation - A Global AI Alliance from Singapore
NYB hosts AI4Life Summit 2025 with global partners – NVIDIA, Hewlett Packard Enterprise, and Equinix – to accelerate AI-Driven biomedical innovation.
Read more
Case Studies
July 4, 2025
NYB Featured in Equinix Global Case Study on AI-Powered Drug Discovery
NYB has been featured as a global case study by Equinix, showcasing how our AI-driven drug discovery is powered by scalable and secure infrastructure.
Read more
Partnership
July 3, 2025
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Advance AI-Powered Hair Regeneration Research
NYB.AI and Pnaseer Inc. partner to advance hair follicle regeneration using AI-powered compound prediction and bio-nanoparticle delivery.
Read more
Company
June 20, 2025
NYB is the Winner of SuperAI Genesis 2025
NYB has been crowned the Winner of the SuperAI Genesis Startup Competition 2025, the world’s premier AI startup showdown at SuperAI Singapore 2025.
Read more
Company
June 16, 2025
NYB Featured in NVIDIA’s Global Startup Showcase at GTC Taipei 2025
NYB has been featured in the NVIDIA’s official video spotlighting standout startups at NVIDIA GTC Taipei 2025.
Read more
Press
May 30, 2025
[The Business Times] Revolutionising drug discovery with AI in South-east Asia
NYB AI is featured in The Business Times for leveraging its AI platform, DTIGN, to accelerate drug discovery in Southeast Asia.
Read more
Press
May 30, 2025
[Tech in Asia] Transforming drug discovery in Southeast Asia via AI
NYB AI is featured in Tech in Asia for pioneering AI-driven drug discovery in Southeast Asia.
Read more
Press
May 30, 2025
[Computer Weekly] Pharma leaders see AI revolutionising medicine
NYB AI is featured in Computer Weekly’s coverage of Gitex Asia 2025, where industry leaders discussed how AI is revolutionizing drug discovery and development.
Read more
Company
May 29, 2025
NYB Showcases AI Drug Discovery at COMPUTEX 2025
NYB showcased AI-driven drug discovery at COMPUTEX 2025 in Taipei, joining global leaders in AI, robotics and next-generation technologies.
Read more
Partnership
May 3, 2025
NYB and Precisya Global Form Strategic Alliance to Leverage AI in Validating Natural Compounds for Genetic Risk Mitigation
NYB & PGI combine AI-powered compound discovery with genetic risk profiling to advance precision health through nature-derived interventions.
Read more
Company
April 18, 2025
NYB at GITEX ASIA SINGAPORE 2025
NYB will be joining GITEX ASIA – Asia’s largest and most global tech, startup, and digital investment event – taking place from April 23 to 25 at Marina Bay Sands, Singapore.
Read more
Company
March 7, 2025
NYB-NTU Joint Laboratory
NYB and NTU Singapore launched the NYB-NTU Joint Laboratory to advance drug discovery using AI and natural compounds.
Read more
Company
March 6, 2025
Unlocking Nature’s Potential for Breakthrough Therapies with DTIGN
NYB’s AI-driven DTIGN platform accelerates natural compound drug discovery through screening of promising therapeutic candidates.
Read more
Peer-Reviewed Publications
March 6, 2025
Publication of DTIGN on IEEE Xplore
NYB IEEE Paper Advances Bioactivity Prediction Through Molecular Docking and Self-Attention.
Read more
Company
March 6, 2025
NYB Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
NYB is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Read more
Partnership
March 4, 2025
NYB Joins Prestigious Johnson & Johnson Innovation JLABS to Accelerate AI-Driven Drug Discovery
NYB becomes a resident company of JLABS, joining a global network dedicated to accelerating life-enhancing health and wellness solutions.
Read more
Partnership
March 3, 2025
NYB Joins NVIDIA & Tribe’s Prestigious Ignition Program
NYB harnesses NVIDIA AI and accelerated computing to transform $7 billion drug discovery industry.
Read more
Partnership
October 2, 2025
NYB Announces $1.5 Billion Business Combination with RF Acquisition Corp II to Pursue Nasdaq Listing
NYB announced a business combination agreement with RF Acquisition Corp II to pursue a Nasdaq listing.
Read more
Partnership
September 3, 2025
Powering Life Sciences and Health Innovation - A Global AI Alliance from Singapore
NYB hosts AI4Life Summit 2025 with global partners – NVIDIA, Hewlett Packard Enterprise, and Equinix – to accelerate AI-Driven biomedical innovation.
Read more
Partnership
July 3, 2025
NYB.AI and Pnaseer Inc. Announce Strategic Partnership to Advance AI-Powered Hair Regeneration Research
NYB.AI and Pnaseer Inc. partner to advance hair follicle regeneration using AI-powered compound prediction and bio-nanoparticle delivery.
Read more
Partnership
May 3, 2025
NYB and Precisya Global Form Strategic Alliance to Leverage AI in Validating Natural Compounds for Genetic Risk Mitigation
NYB & PGI combine AI-powered compound discovery with genetic risk profiling to advance precision health through nature-derived interventions.
Read more
Partnership
March 4, 2025
NYB Joins Prestigious Johnson & Johnson Innovation JLABS to Accelerate AI-Driven Drug Discovery
NYB becomes a resident company of JLABS, joining a global network dedicated to accelerating life-enhancing health and wellness solutions.
Read more
Partnership
March 3, 2025
NYB Joins NVIDIA & Tribe’s Prestigious Ignition Program
NYB harnesses NVIDIA AI and accelerated computing to transform $7 billion drug discovery industry.
Read more
Case Studies
February 23, 2026
How AI Discovered 3,500 Mental Wellness Compounds in 5 Months — What Took Traditional Labs Years
NYB's Vecura platform, powered by NVIDIA GPU infrastructure, is rewriting the rules of natural ingredient discovery.
Read more
Case Studies
July 4, 2025
NYB Featured in Equinix Global Case Study on AI-Powered Drug Discovery
NYB has been featured as a global case study by Equinix, showcasing how our AI-driven drug discovery is powered by scalable and secure infrastructure.
Read more
Peer-Reviewed Publications
June 4, 2026
Introducing LigoSPACE: Advancing Bioactivity Prediction at NeurIPS 2025
NYB and NTU Singapore presented LigoSPACE at NeurIPS 2025, one of the world’s most prestigious conferences in AI and ML.
Read more
Peer-Reviewed Publications
June 4, 2026
Publication of DTIGN on IEEE Xplore
NYB IEEE Paper Advances Bioactivity Prediction Through Molecular Docking and Self-Attention.
Read more
Company
June 3, 2026
Featured at NVIDIA GTC Taiwan 2026: NYB.AI Stands Alongside the World’s Leading AI Innovators
NYB.AI, the AI drug discovery spinoff of NYB Group, was featured in a video during Jensen Huang's keynote at NVIDIA GTC Taiwan 2026 — recognised among the world's leading AI innovators from NVIDIA Inception's ecosystem of 25,000+ startups.
Read more
Company
June 4, 2026
NYB Reflects on NVIDIA GTC 2026: A Week of Discovery, Dialogue, and Momentum
NYB at GTC 2026 with valuable scientific exchange, external feedback, and cross-sector dialogue.
Read more
Company
June 4, 2026
NYB to Exhibit at NVIDIA GTC 2026
NYB is pleased to announce that we will be exhibiting at NVIDIA GTC 2026, taking place from March 16–19, 2026.
Read more
Company
June 4, 2026
NYB is the Winner of SuperAI Genesis 2025
NYB has been crowned the Winner of the SuperAI Genesis Startup Competition 2025, the world’s premier AI startup showdown at SuperAI Singapore 2025.
Read more
Company
June 4, 2026
NYB Featured in NVIDIA’s Global Startup Showcase at GTC Taipei 2025
NYB has been featured in the NVIDIA’s official video spotlighting standout startups at NVIDIA GTC Taipei 2025.
Read more
Company
June 4, 2026
NYB Showcases AI Drug Discovery at COMPUTEX 2025
NYB showcased AI-driven drug discovery at COMPUTEX 2025 in Taipei, joining global leaders in AI, robotics and next-generation technologies.
Read more
Company
June 4, 2026
NYB at GITEX ASIA SINGAPORE 2025
NYB will be joining GITEX ASIA – Asia’s largest and most global tech, startup, and digital investment event – taking place from April 23 to 25 at Marina Bay Sands, Singapore.
Read more
Company
June 4, 2026
NYB-NTU Joint Laboratory
NYB and NTU Singapore launched the NYB-NTU Joint Laboratory to advance drug discovery using AI and natural compounds.
Read more
Company
June 4, 2026
Unlocking Nature’s Potential for Breakthrough Therapies with DTIGN
NYB’s AI-driven DTIGN platform accelerates natural compound drug discovery through screening of promising therapeutic candidates.
Read more
Company
June 4, 2026
NYB Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
NYB is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Read more
.jpg)
![[The Business Times] Singapore biotech startup NYB bets on AI drug discovery platform to unlock revenue](https://cdn.prod.website-files.com/69f83b3c29e5eb116f35ca2b/6a0b1e7ad3c385a1d4ec8a02_69f85310d7cfb9e559f44551_691d714a327df4d7c6c9b643_Roland_thumbnail.png)
.jpg)
.jpeg)
.jpg)
![[The Business Times] Revolutionising drug discovery with AI in South-east Asia](https://cdn.prod.website-files.com/69f83b3c29e5eb116f35ca2b/69f8530ff4ec08e028d01c7f_683961f9d3018e78d8b91e63_Banner%2520website.jpeg)
![[Tech in Asia] Transforming drug discovery in Southeast Asia via AI](https://cdn.prod.website-files.com/69f83b3c29e5eb116f35ca2b/69f8530f616cc0aa1fad165f_68396388503a0525d4d7df39_4.jpeg)
![[Computer Weekly] Pharma leaders see AI revolutionising medicine](https://cdn.prod.website-files.com/69f83b3c29e5eb116f35ca2b/69f8530e5f5346107748c12f_6839659a771ee52a6e9248cf_Banner%2520website%2520(1).jpeg)
